About DaylightRx
DaylightRx is an FDA-cleared prescription digital therapeutic that delivers guideline-recommended cognitive behavioral therapy for generalized anxiety disorder through a mobile app. The treatment uses video and audio lessons designed by anxiety experts to help patients understand and address the thoughts and behaviors that sustain anxiety. Clinical trials demonstrate that 71% of DaylightRx users achieve clinical improvement in anxiety symptoms, with lasting benefits beyond program completion. As the first-line treatment recommended by the Anxiety and Depression Association of America, DaylightRx is now reimbursable under Medicare with CMS billing codes effective January 2025, expanding access to evidence-based mental health care.
Best For
- • Psychiatrists
- • psychologists
- • and primary care providers treating patients with generalized anxiety disorder who may benefit from app-based CBT
Not Ideal For
- • Patients with severe anxiety requiring intensive outpatient or inpatient treatment
- • or those with primary diagnoses other than GAD
Pricing
Contact for pricing
Compliance & Security
Always verify compliance directly with the vendor.
Target Audience
Roles
Settings
Related Tools
SleepioRx
FDA-cleared CBT-I digital therapeutic for insomnia
Daylight (DaylightRx)
First FDA-cleared digital therapeutic for GAD with 71% improvement rate.
SparkRx
Digital therapeutic for teen and young adult depression
Akili Interactive (EndeavorRx, EndeavorOTC)
First FDA-cleared video game digital therapeutic for ADHD in children and adults.